CIK 0001125345
- Non-accelerated filer
- Smaller reporting company
MACROGENICS INC
Sign in to watch- Ticker
- MGNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-251-5172
- Business address
- 9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-20 | Risser Eric Blasius Sr VP & Chief Business Officer | Sale | −3,000 | $18.38 | $55K | 30,806 |
| 2019-05-20 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion · Employee stock option (right to buy) | −3,000 | 7,653 | ||
| 2019-05-16 | SIEGEL JAY PHILIP Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2019-05-16 | Ferrante Karen Jean Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2019-05-16 | Ferrante Karen Jean Director | Grant or award · Stock Option (right to buy) | +4,616 | 4,616 | ||
| 2019-05-16 | Galbraith Kenneth Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2019-05-16 | Costa Paulo F Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2019-05-16 | Costa Paulo F Director | Grant or award · Stock Option (right to buy) | +7,357 | 7,357 | ||
| 2019-05-16 | HURWITZ EDWARD Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2019-05-16 | STUMP DAVID C Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2019-05-16 | Jackson Scott Thomas Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2019-05-16 | Fust Matthew K Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2019-03-14 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion | +2,497 | $0.94 | $2K | 30,806 |
| 2019-03-14 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion · Employee stock option (right to buy) | −2,497 | 0 | ||
| 2019-02-21 | Risser Eric Blasius Sr VP & Chief Business Officer | Grant or award · Employee stock option (right to buy) | +85,000 | 85,000 | ||
| 2019-02-21 | Spitznagel Thomas Sr VP, BPD & Manufacturing | Grant or award · Employee stock option (right to buy) | +70,000 | 70,000 | ||
| 2019-02-21 | Karrels James SVP, CFO and Secretary | Grant or award · Employee stock option (right to buy) | +85,000 | 85,000 | ||
| 2019-02-21 | Wigginton Jon Marc Sr VP, Clinical Dev. & CMO | Grant or award · Employee stock option (right to buy) | +90,000 | 90,000 | ||
| 2019-02-21 | Cilinski Lynn VP, Controller and Treasurer | Grant or award · Employee stock option (right to buy) | +35,000 | 35,000 | ||
| 2019-02-21 | Bonvini Ezio Sr VP, Research & CSO | Grant or award · Employee stock option (right to buy) | +90,000 | 90,000 |
Page 29 of 35 · 684 trades